Literature DB >> 24507167

Prognosis in patients hospitalized with permanent and nonpermanent atrial fibrillation in heart failure.

Sophie Taillandier1, Anne Brunet Bernard1, Benedicte Lallemand1, Edouard Simeon1, Lauriane Pericart1, Nicolas Clementy1, Dominique Babuty1, Laurent Fauchier2.   

Abstract

Atrial fibrillation (AF) and heart failure (HF) frequently coexist and are associated with an increased mortality. This study evaluated the prognosis of permanent and nonpermanent AF in patients with both AF and HF. All AF patients seen in our institution were identified and followed up. We included 1,906 patients suffering from AF and HF: 839 patients (44%) had preserved left ventricular ejection fraction (LVEF) and 1,067 patients (56%) had decreased LVEF; 1,056 patients (55%) had nonpermanent AF and 850 patients (45%) had permanent AF. During a median follow-up of 1.9 years (interquartile range 0.3 to 5.0), 377 patients died, 462 were readmitted for HF, and 200 had stroke or thromboembolic events. In patients with decreased LVEF, the rate of death was similar in patients with permanent or nonpermanent AF. In patients with preserved LVEF, permanent AF was associated with a higher risk of death and a higher risk of HF hospitalization. Stroke risk did not differ with permanent AF whatever the LVEF. NYHA functional class was an independent predictor of death (risk ratio [RR]=1.33, 95% confidence interval [CI] 1.12 to 1.59, p=0.001), as was permanent AF (RR=1.79, 95%CI 1.32 to 2.42, p=0.0002). Permanent AF (RR=1.52, 95% CI 1.20 to 1.93, p=0.0006) was also an independent predictor of readmission for HF. In conclusion, in patients with AF and HF, the risk of admission for HF and risk of death were higher when AF was permanent, particularly in patients with preserved LVEF. Stroke risk did not differ according to the pattern of AF, whatever the LVEF.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24507167     DOI: 10.1016/j.amjcard.2013.12.024

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

1.  Paroxysmal and Non-Paroxysmal Atrial Fibrillation in Middle Eastern Patients: Clinical Features and the Use of Medications. Analysis of the Jordan Atrial Fibrillation (JoFib) Study.

Authors:  Hanna Al-Makhamreh; Nasr Alrabadi; Lubna Haikal; Mohammad Krishan; Noor Al-Badaineh; Osama Odeh; Tawfiq Barqawi; Mohammed Nawaiseh; Ala Shaban; Basil Abdin; Lama Khamies; Ayman Hammoudeh
Journal:  Int J Environ Res Public Health       Date:  2022-05-19       Impact factor: 4.614

2.  Calpain-Calcineurin-Nuclear Factor Signaling and the Development of Atrial Fibrillation in Patients with Valvular Heart Disease and Diabetes.

Authors:  Yong Zhao; Guo-Ming Cui; Nan-Nan Zhou; Cong Li; Qing Zhang; Hui Sun; Bo Han; Cheng-Wei Zou; Li-Juan Wang; Xiao-Dong Li; Jian-Chun Wang
Journal:  J Diabetes Res       Date:  2016-03-31       Impact factor: 4.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.